Search

everythinglearnresearchcommunity

for

Search:↓

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Alefacept does not effectively treat severe alopecia areata.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Abatacept may help some people with alopecia areata regrow hair.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

Baricitinib works better than methotrexate for severe alopecia areata.

The higher dose supplement was more effective in treating female hair loss.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.